{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "65862-390",
      "generic_name": "Ondansetron",
      "labeler_name": "Aurobindo Pharma Limited",
      "brand_name": "Ondansetron",
      "active_ingredients": [
        {
          "name": "ONDANSETRON",
          "strength": "4 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "65862-390-02",
          "description": "100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (65862-390-02)",
          "marketing_start_date": "20240412",
          "sample": false
        },
        {
          "package_ndc": "65862-390-05",
          "description": "500 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (65862-390-05)",
          "marketing_start_date": "20240412",
          "sample": false
        },
        {
          "package_ndc": "65862-390-10",
          "description": "3 BLISTER PACK in 1 CARTON (65862-390-10)  / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK",
          "marketing_start_date": "20100412",
          "sample": false
        },
        {
          "package_ndc": "65862-390-19",
          "description": "10000 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (65862-390-19)",
          "marketing_start_date": "20100412",
          "sample": false
        },
        {
          "package_ndc": "65862-390-30",
          "description": "30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (65862-390-30)",
          "marketing_start_date": "20100412",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Aurobindo Pharma Limited"
        ],
        "rxcui": [
          "104894",
          "312087"
        ],
        "spl_set_id": [
          "cab63f24-8728-4927-aba5-53e8d2e44cdb"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000175817",
          "N0000175818"
        ],
        "pharm_class_moa": [
          "Serotonin 3 Receptor Antagonists [MoA]"
        ],
        "pharm_class_epc": [
          "Serotonin-3 Receptor Antagonist [EPC]"
        ],
        "unii": [
          "4AF302ESOS"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET, ORALLY DISINTEGRATING",
      "spl_id": "aab5d8ee-a492-4deb-b240-62b1b0eb0aa8",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20100412",
      "product_id": "65862-390_aab5d8ee-a492-4deb-b240-62b1b0eb0aa8",
      "application_number": "ANDA090469",
      "brand_name_base": "Ondansetron",
      "pharm_class": [
        "Serotonin 3 Receptor Antagonists [MoA]",
        "Serotonin-3 Receptor Antagonist [EPC]"
      ]
    }
  ]
}